local
Allergy medication recall: Cetirizine tablets pulled over contamination risk
Summary by The Minneapolis Editorial Desk · Based on reporting by Chris Williams , FOX 9 KMSP (FOX)
· July 22, 2026
· 1 min read
Unique Pharmaceutical Laboratories is voluntarily recalling four nationwide lots of Cetirizine Hydrochloride Tablets USP 5 mg after discovering the allergy medication may be cross-contaminated with ranitidine, according to the FDA.
Story provenance No corrections
Summary created by The Minneapolis Editorial Desk — automated, rule-governed Original reporting Chris Williams, FOX 9 KMSP (FOX) Original story Read at the source Source published Jul 22, 2026 Indexed here Jul 22, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Why this matters in The Minneapolis
For Minneapolis residents who rely on Cetirizine Hydrochloride Tablets to manage their allergies, the recall of these medications due to potential contamination with ranitidine is a concern. Given the widespread use of allergy medications in the Twin Cities area, particularly during peak pollen seasons, it's crucial for local pharmacies and healthcare providers to promptly notify patients who may have been prescribed the affected lots. The contamination risk associated with ranitidine, a medication that has been linked to health issues in the past, adds an extra layer of urgency to the recall. As the recall process unfolds, Minneapolis consumers should be vigilant about checking their medication labels and consulting with their healthcare providers or pharmacists if they have any questions or concerns about the safety of their medications. Local health officials will likely be monitoring the situation closely to ensure that residents are protected from potential harm.
About this story
Original reporting by FOX 9 KMSP (FOX) . The Minneapolis surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit FOX 9 KMSP (FOX) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 22, 2026 ·
Source: FOX 9 KMSP (FOX) ·
Reading time: 1 min
Frequently asked about this story
What is this story about? Unique Pharmaceutical Laboratories is voluntarily recalling four nationwide lots of Cetirizine Hydrochloride Tablets USP 5 mg after discovering the allergy medication may be cross-contaminated with ranitidine, according to the FDA.
When was this published? This article was first published on July 22, 2026 by FOX 9 KMSP (FOX) and curated for The Minneapolis readers.
Who reported this story? This story was reported by Chris Williams at FOX 9 KMSP (FOX). To learn more about how The Minneapolis selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Minneapolis, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter